Nawaf Alkhayat
Overview
Explore the profile of Nawaf Alkhayat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamzi H, Binhassan A, Najmeldin A, Alhariri E, Elhussein B, Althibani N, et al.
J Egypt Natl Canc Inst
. 2024 Dec;
36(1):38.
PMID: 39617846
Background: Severe oral mucositis (OM) is one of the adverse events post-chemotherapy, radiation, and stem cell transplantation with major clinical and economic impact. The management of severe OM remains challenging....
2.
Alkhayat N, Alshahrani M, Elyamany G, Sedick Q, Ibrahim W, Hamzi H, et al.
J Egypt Natl Canc Inst
. 2021 Aug;
33(1):21.
PMID: 34396456
Background: Hodgkin lymphoma (HL) is lymphoid neoplasm usually affecting lymphatic system; it accounts 3.6% of cancers in Saudi Arabia. Modern treatment protocols had shown particular success rates in overall-survival (OS)...
3.
Alabbas F, Elyamany G, Alkhayat N, Alshahrani M, Ibrahim W, Elborai Y, et al.
Health Serv Insights
. 2021 Jul;
14:11786329211029351.
PMID: 34285506
Advances in pediatric cancer treatment and dramatic improvement in long-term survival have made health-related quality of life (HRQOL) a priority. This study describes the HRQOL of Saudi children on cancer...
4.
Elyamany G, Akhter A, Kamran H, Rizwan H, Shabani-Rad M, Alkhayat N, et al.
Pediatr Hematol Oncol
. 2021 Mar;
38(6):581-592.
PMID: 33764257
Genetic aberrations in the epigenome are rare in pediatric AML, hence expression data in epigenetic regulation and its downstream effect is lacking in childhood AML. Our pilot study screened epigenetic...
5.
Elborai Y, Alkhayat N, Elyamany G, Alshahrani M, Ibrahim W, Othman M, et al.
Rare Tumors
. 2021 Mar;
13:2036361321997331.
PMID: 33708364
Rare pediatric tumors are heterogeneous group containing a variety of histopathological diseases, they represent approximately 10% of all childhood cancers. These rare tumors had a diversity of histology and clinical...
6.
Alshahrani M, Elyamany G, Sedick Q, Ibrahim W, Mohamed A, Othman M, et al.
Health Serv Insights
. 2021 Jan;
13:1178632920984161.
PMID: 33447044
In January 2020, the WHO declared the novel coronavirus (2019-nCoV) outbreak as a public health emergency of international concern. Due to the rapid spread of 2019-nCoV, all countries started preventive...
7.
Alsultan A, Aljefri A, Ayas M, AlHarbi M, Alkhayat N, Al-Anzi F, et al.
East Mediterr Health J
. 2020 Nov;
26(11):1355-1362.
PMID: 33226103
Background: Travel burden has a substantial psychosocial impact and financial strain on childhood cancer patients and their families. Aims: To study the geographic distribution of childhood cancer and assess the...
8.
Albulushi B, Thabet F, Alshahwan S, Elborai Y, Alkhayat N, Alshahrani M, et al.
Arch Dis Child Educ Pract Ed
. 2020 Sep;
106(2):125-128.
PMID: 32900776
Acute weakness and dyspnoea are unusual presentation after allogeneic haematopoietic stem cell transplantation (HSCT) complicated by chronic graft-versus-host disease (GVHD). The differential diagnosis and management are challenging for the paediatrician....
9.
Alsultan A, Essa M, Aljefri A, Ayas M, AlHarbi M, Alkhayat N, et al.
Pediatr Blood Cancer
. 2020 May;
67(7):e28340.
PMID: 32359129
Background: The frequency of pathogenic/likely pathogenic (P/LP) germline mutations in cancer-related genes among children with cancer in highly consanguineous populations is not well studied. Methods: Whole-exome sequencing of germline DNA...
10.
Alkhayat N, Elyamany G, Elborai Y, Sedick Q, Alshahrani M, Al Sharif O, et al.
Mol Cytogenet
. 2019 Oct;
12:42.
PMID: 31632455
Background: Childhood Acute Leukemia (AL) is characterized by recurrent genetic aberrations in 60% of AML cases and 90% of ALL cases. Insufficient data exists of rare cytogenetic abnormalities in AL....